Table 1 Clinical features of case reports of breast metastasis from pulmonary adenocarcinoma with micropapillary components
Authors, year | Age/Sex | Chief complaint | Method of detection for breast tumor | Breast tumor size | Metachronous | Initial stage of lung cancer | Management | Chemotherapy regimen | Survival | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|
Ko K, et al., 2012 [12] | 47/F | Chest pain with dyspnea | Palpable mass on P/Ex. | 1 cm in diameter | No | IV | Chemotherapy | Cisplatin/Irinotecan followed by erotinib | Alive | 8 mo |
Maounis N, et al., 2010 [13] | 73/F | Dyspnea with dry cough | Palpable mass on P/Ex | Not available | No | IV | Chemotherapy | Cisplatin/docetaxel/bevacizumab | Dead | 6 mo |
Sanguinetti A, et al., 2013 [14] | 43/F | Dyspnea with dry cough | Palpable mass on P/Ex | Not available | No | IV | Simple mastectomy + Chemotherapy | Cisplatin/docetaxel/bevacizumab | Dead | 8 mo |
This report | 47/F | Breast nodule on screening exam | Ultrasonography | 1.3 cm ×1 cm | Yes | IB | Lumpectomy + Chemotherapy | Gefitinib | Alive | 23 mo |